详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

MA11.09 Progastrin-Releasing Peptide (ProGRP) to Rule out Progressive Disease in Patients with Small Cell Lung Carcinoma (SCLC)

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]Translational Research Unit (Stf), Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Thoraxklinik at Heidelberg University Hospital, Heidelberg/Germany, [2]Peking Union Medical College Hospital (PUMCH), Beijing/ China [3]University of Bonn, Bonn/Germany, [4]The Netherlands Cancer Institute, Amsterdam/Netherlands, [5]Xuanwu Hospital, Capital Medical University, Beijing/ China, [6]Hospital Clinic, University of Barcelona, Barcelona/Spain, [7]Roche Diagnostics GmbH, Penzberg/ Germany, [8]Roche Diagnostics International, Rotkreuz/ Switzerland

出处：

DOI：

ISSN：

关键词： SCLC ProGRP

语种：

WOS：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2015]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 5.04 出版当年[2015版] 4.932 出版当年五年平均 5.282 出版前一年[2014版] 6.595 出版后一年[2016版]

第一作者：

第一作者机构： [1]Translational Research Unit (Stf), Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Thoraxklinik at Heidelberg University Hospital, Heidelberg/Germany,

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Progastrin-Releasing Peptide (ProGRP) to Rule out Progressive Disease in Patients with Small Cell Lung Carcinoma (SCLC) [2]Progastrin-Releasing Peptide (ProGRP) as a Biomarker for Clinical Response in Small-Cell Lung Carcinoma (SCLC) [3]Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China [4]一项在欧洲和中国进行的新型胃泌素释放肽前体(ProGRP)免疫检测多中心评估研究 [5]肿瘤标志物ProGRP助力小细胞肺癌的临床决策 [6]Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients [7]Study on Biodistribution and Radioimmunoimaging of (131)Iodine-Labeled Monoclonal Antibody D-D3 Against Progastrin-Releasing Peptide((31-98)) in Tumor-Bearing Mouse [8]A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test(Open Access) [9]高龄病人麻醉监测规范 [10]